Methotrexate shows marginal clinical efficiency in early scleroderma.

John Varga

doi:10.1007/s11926-002-0003-3

Methotrexate shows marginal clinical efficiency in early scleroderma.

John Varga^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	97-98
Number of pages	2
Journal	Current Rheumatology Reports
Volume	4
Issue number	2
DOIs	https://doi.org/10.1007/s11926-002-0003-3
State	Published - Jan 1 2002

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s11926-002-0003-3

Cite this

@article{8e3e55ca9ba14917b3249bec5b58df0d,

title = "Methotrexate shows marginal clinical efficiency in early scleroderma.",

author = "John Varga",

year = "2002",

month = jan,

day = "1",

doi = "10.1007/s11926-002-0003-3",

language = "English (US)",

volume = "4",

pages = "97--98",

journal = "Current Rheumatology Reports",

issn = "1523-3774",

publisher = "Current Science, Inc.",

number = "2",

}

TY - JOUR

T1 - Methotrexate shows marginal clinical efficiency in early scleroderma.

AU - Varga, John

PY - 2002/1/1

Y1 - 2002/1/1

UR - http://www.scopus.com/inward/record.url?scp=0036546541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036546541&partnerID=8YFLogxK

U2 - 10.1007/s11926-002-0003-3

DO - 10.1007/s11926-002-0003-3

M3 - Article

C2 - 11890873

AN - SCOPUS:0036546541

SN - 1523-3774

VL - 4

SP - 97

EP - 98

JO - Current Rheumatology Reports

JF - Current Rheumatology Reports

IS - 2

ER -

Methotrexate shows marginal clinical efficiency in early scleroderma.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this